SCHEMBL3588249

SCHEMBL3588249

CN(C(=O)CCl)c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIB P23284 2/20 0.46
ALDH1A1 P00352 11/20 0.45
CYP3A4 P08684 3/20 0.45
MAPK1 P28482 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
TP53 P04637 2/20 0.45
ALOX15 P16050 1/20 0.45
HTT P42858 5/20 0.41
KMT2A Q03164 4/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 2/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.41
PSMD14 O00487 1/20 0.41
RECQL P46063 1/20 0.41
GFER P55789 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.40
LMNA P02545 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19879909 0.90 ALDH1A1 (0.48) ALDH1A1TDP1TP53HTTKMT2A
SCHEMBL5351542 0.82 ALDH1A1 (0.58) ALDH1A1TDP1HTTKMT2ARAB9A
SCHEMBL737988 0.82 ALDH1A1 (0.47) PPIBALDH1A1CYP3A4MAPK1TDP1
SCHEMBL11635095 0.82 RAB9A (0.46) ALDH1A1TP53HTTKMT2ARAB9A
SCHEMBL4506617 0.82 PPIB (0.47) PPIBALDH1A1CYP3A4MAPK1TDP1
SCHEMBL6247670 0.82 ALDH1A1 (0.42) ALDH1A1TP53HTTKMT2ARAB9A
SCHEMBL22311426 0.81 POLQ (0.48) ALDH1A1HTTKMT2ARAB9ANPC1
SCHEMBL4487778 0.81 HIF1A (0.42) ALDH1A1TP53HTTKMT2ARAB9A
SCHEMBL3145218 0.81 PPIB (0.46) PPIBALDH1A1CYP3A4MAPK1TDP1
SCHEMBL1507876 0.80 ALDH1A1 (0.64) ALDH1A1TDP1TP53HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016178064-A1 POLYMORPH OF NINTEDANIB ETHANESULPHONATE, PROCESSES AND INTERMEDIATES THEREOF SUVEN LIFE SCIENCES LIMITED (IN) 2016-11-10 WO disclosed
US-7732481-B2 Prolinylarylacetamides MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-06-08 US disclosed
US-7732481-B2 Prolinylarylacetamides MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-06-08 US disclosed
US-7732481-B2 Prolinylarylacetamides MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-06-08 US disclosed
EP-1697318-B1 PROLINYLARYLACETAMIDES MERCK PATENT GMBH (DE) 2008-08-27 EP disclosed
EP-1697318-B1 PROLINYLARYLACETAMIDES MERCK PATENT GMBH (DE) 2008-08-27 EP disclosed
US-20070185189-A1 Prolinylarylacetamides MERCK PATENT GMBH (DE) 2007-08-09 US disclosed
US-20070185189-A1 Prolinylarylacetamides MERCK PATENT GMBH (DE) 2007-08-09 US disclosed
US-20070185189-A1 Prolinylarylacetamides MERCK PATENT GMBH (DE) 2007-08-09 US disclosed
CN-1036564-C Herbicidal glutarmides ROHM & HAAS (US) 1997-12-03 CN disclosed
US-5631209-A ALGICIDES ROHM AND HAAS COMPANY (US) 1997-05-20 US disclosed
US-5502027-A ALGICIDES ROHM AND HAAS COMPANY (US) 1996-03-26 US disclosed
EP-0415642-B1 Glutarimides ROHM & HAAS (US) 1995-12-06 EP disclosed
EP-0664283-A1 P-phenylenediamine derivatives and fungicidal agents containing them BASF Aktiengesellschaft (DE) 1995-07-26 EP disclosed
US-5393735-A N-(halo-oxy-)phenyl substituted cyclic imides ROHM AND HAAS COMPANY (US) 1995-02-28 US disclosed
CN-1049846-A Glutarimide with weeding activity ROHM & HAAS (US) 1991-03-13 CN disclosed
EP-0415642-A1 Glutarimides ROHM AND HAAS COMPANY (US) 1991-03-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185189-A1 Prolinylarylacetamides F12, F11, F2 PPIB 130/4885ALDH1A1 1510/4885CYP3A4 1326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.